The MGH Epilepsy Service offers training opportunities for physicians, including visiting scientist opportunities and clinical and research fellowships. Our clinical focus is on the advancement of knowledge about paroxysmal neurological dysfunction.
The MGH Epilepsy Service maintains an active research program involving projects ranging from healthcare outcomes research to advanced neuroimaging techniques to basic molecular studies of mechanisms of disease.
Clinical Trials
- Human Epilepsy Project
- SGE-547 for Treatment of Refractory Status Epilepticus: An Open Label Trial
- Neuropace responsive neurostimulator trial
- Cognitive effects of treatment of interictal discharges with levetiracetam and lamotrigine
- Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures
Imaging Research
- Functional MRI of language
- PET studies of vagal nerve stimulation
- Advanced neuroimaging and MEG studies